The identification of irreversible rituximab-resistant lymphoma caused by CD20 gene mutations

C-terminal mutations of CD20 constitute part of the mechanisms that resist rituximab therapy. Most CD20 having a C-terminal mutation was not recognized by L26 antibody. As the exact epitope of L26 has not been determined, expression and localization of mutated CD20 have not been completely elucidate...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Mishima, Y, Terui, Y, Takeuchi, K, Matsumoto-Mishima, Y, Matsusaka, S, Utsubo-Kuniyoshi, R, Hatake, K
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2011
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3255244/
https://ncbi.nlm.nih.gov/pubmed/22829136
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2011.11
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia